These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18261537)

  • 1. Effects of losartan and enalapril on high-sensitivity C-reactive protein and total antioxidant in renal transplant recipients with Renin-Angiotensin system polymorphisms.
    Argani H; Ghorbanihaghjo A; Aghaeishahsavari M; Noroozianavval M; Rashtchizadeh N; Veisi P; Safa J; Abediazar S
    Transplant Proc; 2008; 40(1):16-21. PubMed ID: 18261537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enalapril and losartan affect lipid peroxidation in renal transplant recipients with renin-angiotensin system polymorphisms.
    Rashtchizadeh N; Aghaeishahsavari M; Argani H; Noroozianavval M; Veisi P; Ghorbanihaghjo A
    Clin Biochem; 2007 Feb; 40(3-4):194-200. PubMed ID: 17222813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-angiotensin system polymorphisms and hemoglobin level in renal allografts: a comparative study between losartan and enalapril.
    Noroozianavval M; Argani H; Aghaeishahsavari M; Veisi P; Ghorbanihaghjo A; Rashtchizadeh N; Jabbarpourbonyadi M; Hamzeiy H
    Transplant Proc; 2007 May; 39(4):1018-22. PubMed ID: 17524880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of DNA damage in renal transplantation by losartan and enalapril: the role of renin-angiotensin system polymorphisms.
    Ghorbanihaghjo A; Veisi P; Argani H; Aghaeishahsavari M; Noroozianavval M; Rashtchizadeh N; Mesgari M; Safa J; Babaei H
    Clin Exp Nephrol; 2008 Feb; 12(1):65-73. PubMed ID: 18175066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-angiotensin system polymorphisms and renal graft function in renal transplant recipients.
    Argani H; Noroozianavval M; Aghaeishahsavari M; Veisi P; Rashtchizadeh N; Ghorbanihaghjo A; Bonyadi M; Asgarzadeh M; Hamzeiy H
    Saudi Med J; 2007 Oct; 28(10):1496-502. PubMed ID: 17914507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial nitric oxide synthase and angiotensin II type 1 receptor gene polymorphisms can influence chronic inflammatory state in renal transplant patients.
    Sezer S; Uyar M; Akcay A; Arat Z; Kulah E; Ozdemir FN; Haberal M
    Transplant Proc; 2005 Mar; 37(2):776-8. PubMed ID: 15848528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin-angiotensin system polymorphisms: a risk factor for progression to end-stage renal disease in vesicoureteral reflux patients.
    Akman B; Tarhan C; Arat Z; Sezer S; Ozdemir FN
    Ren Fail; 2009; 31(3):196-200. PubMed ID: 19288324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure.
    Madsen T; Schmidt EB; Christensen JH
    J Ren Nutr; 2007 Jul; 17(4):258-63. PubMed ID: 17586424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renoprotective effect of early inhibition of the renin-angiotensin system in renal transplant recipients.
    Montanaro D; Gropuzzo M; Tulissi P; Vallone C; Boscutti G; Mioni R; Risaliti A; Baccarani U; Adani GL; Sainz M; Bresadola F; Mioni G
    Transplant Proc; 2005 Mar; 37(2):991-3. PubMed ID: 15848600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the genetic polymorphisms of the renin-angiotensin system with kidney graft long-term outcome: preliminary results.
    Rodríguez-Moreno A; Sánchez-Fructuoso AI; Ridao-Cano N; Calvo N; Conesa J; Gómez-Gallego F; Santiago C; Bandrés F; Barrientos A
    Transplant Proc; 2005 Nov; 37(9):3716-7. PubMed ID: 16386515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A1166C angiotensin II type 1 receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension.
    Sookoian S; Castaño G; García SI; Viudez P; González C; Pirola CJ
    Am J Gastroenterol; 2005 Mar; 100(3):636-42. PubMed ID: 15743363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study.
    Hanefeld M; Marx N; Pfützner A; Baurecht W; Lübben G; Karagiannis E; Stier U; Forst T
    J Am Coll Cardiol; 2007 Jan; 49(3):290-7. PubMed ID: 17239709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No association between renin-angiotensin system gene polymorphisms and early and long-term allograft dysfunction in kidney transplant recipients.
    Slowinski T; Diehr P; Kleemann P; Fritsche L; Renders L; Budde K; Hauser IA; Neumayer HH; Hocher B
    Nephrol Dial Transplant; 2004 Nov; 19(11):2846-51. PubMed ID: 15353577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes seen in the aging kidney and the effect of blocking the renin-angiotensin system.
    Inserra F; Basso N; Ferder M; Userpater M; Stella I; Paglia N; Inserra P; Tenembaum D; Ferder L
    Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):341-6. PubMed ID: 19574289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of angiotensin II type 1 receptor in the regulation of cellular adhesion molecules in atherosclerosis.
    Prasad A; Koh KK; Schenke WH; Mincemoyer R; Csako G; Fleischer TA; Brown M; Selvaggi TA; Quyyumi AA
    Am Heart J; 2001 Aug; 142(2):248-53. PubMed ID: 11479463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-angiotensin system genetic polymorphisms: lack of association with CRP levels in patients with coronary artery disease.
    Bahramali E; Firouzabadi N; Jonaidi-Jafari N; Shafiei M
    J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):559-65. PubMed ID: 23392788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of genetic polymorphisms of the renin-angiotensin system in children with nephrotic syndrome.
    Tabel Y; Berdeli A; Mir S; Serdaroğlu E; Yilmaz E
    J Renin Angiotensin Aldosterone Syst; 2005 Dec; 6(3):138-44. PubMed ID: 16525944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two good reasons for an angiotensin-II type 1 receptor blockade with losartan after cardiac transplantation: reduction of incidence and severity of transplant vasculopathy.
    Richter MH; Richter HR; Olbrich HG; Mohr FW
    Transpl Int; 2003 Jan; 16(1):26-32. PubMed ID: 12545338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
    Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pitavastatin further decreases serum high-sensitive C-reactive protein levels in hypertensive patients with hypercholesterolemia treated with angiotensin II, type-1 receptor antagonists.
    Yoshika M; Komiyama Y; Masuda M; Yokoi T; Masaki H; Ohkura H; Takahashi H
    Clin Exp Hypertens; 2010; 32(6):341-6. PubMed ID: 21028996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.